|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:AES_Laboratoire
gptkb:Applied_Maths
gptkb:Invisible_Sentinel
gptkb:Organon_Teknika
gptkb:BioFire_Diagnostics
|
|
gptkbp:awards
|
gptkb:Prix_Galien
|
|
gptkbp:CEO
|
gptkb:Alexandre_Mérieux
|
|
gptkbp:country
|
gptkb:France
|
|
gptkbp:focus
|
food safety testing
infectious disease diagnostics
pharmaceutical quality control
|
|
gptkbp:foundedBy
|
gptkb:Alain_Mérieux
|
|
gptkbp:foundedYear
|
1963
|
|
gptkbp:headquartersLocation
|
gptkb:Marcy-l'Étoile,_France
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
bioMérieux
|
|
gptkbp:industry
|
gptkb:biotechnology
diagnostics
|
|
gptkbp:ISIN
|
FR0013280286
|
|
gptkbp:listedOn
|
gptkb:CAC_Mid_60
|
|
gptkbp:memberOf
|
gptkb:French_Healthcare_Association
|
|
gptkbp:notableProduct
|
gptkb:BACT/ALERT
gptkb:FilmArray
gptkb:VIDAS
gptkb:VITEK
|
|
gptkbp:numberOfEmployees
|
over 13,000
|
|
gptkbp:operatesIn
|
over 160 countries
|
|
gptkbp:parentCompany
|
gptkb:Institut_Mérieux
|
|
gptkbp:products
|
molecular diagnostics
immunoassays
in vitro diagnostics
microbiology testing
|
|
gptkbp:revenue
|
€3.6 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:Euronext_Paris
|
|
gptkbp:stockSymbol
|
BIM
|
|
gptkbp:subsidiary
|
gptkb:Institut_Mérieux
|
|
gptkbp:website
|
https://www.biomerieux.com/
|
|
gptkbp:bfsParent
|
gptkb:Stéphane_Bancel
|
|
gptkbp:bfsLayer
|
5
|